Christine Scheve

Director and Scientific Advisor 

Christine In The News:

Christine Scheve advises the scientific direction of Powershift’s startup initiatives. She also manages the strategic insight for developing research portfolios and programs for a stealth Powershift company. As part of this role, Christine acts as a liaison with key research and industrial partners in various sectors of emerging technology. She has over eight years of biomedical research experience, concentrating in areas such as tissue engineering, drug delivery, molecular biophysics and nanotechnology.

Prior to joining Powershift, she worked for a top-level clinical, regulatory, quality and distribution consulting firm that specialized in medical and in vitro diagnostic devices. Working within Business Development, Christine expanded and maintained up-to-date regulatory knowledge on all major world markets including Europe, the Middle East, Africa, Asia Pacific, Latin America, and North America.

In 2013 Christine worked as a graduate research associate in the Department of Biomedical Engineering at the University of Texas at Austin. Specializing in molecular biophysics and nanotechnology, Christine focused on the optimization of liposomal uptake through improved interaction with the cellular membrane for enhanced pharmaceutical delivery. As a result of this research, Christine published “Steric Pressure Between Membrane-bound Proteins Opposes Lipid Phase Separation” in the Journal of the American Chemical Society.

In 2010, Christine worked as a research scientist in the Department of Nanomedicine at The Methodist Hospital Research Institute. There she conducted research in tissue engineering, drug delivery and nanotechnology. As part of this research, Christine worked on the DARPA funded project involving the development of BioNanoScaffold for post-traumatic osteoregeneration, and the creation of novel porous inorganic, organic, and hybrid nanoparticles for pharmaceutical delivery and targeting. While in this position, Christine presented at numerous conferences including the Biomedical Engineering Society, Biophysical Society, and the Control Release Society and published several articles regarding this work. She also wrote the Introduction chapter for the “Introduction to the World of Nanotechnology” in the Nanotechnology Commercialization for Managers and Scientists.

As a research associate at the Department of Chemical Engineering at The University of Waterloo in Canada in 2008, Christine worked on the development of self-assembled nano-carriers of chosen immunogenic HIV epitopes for HIV delivery. She was also a recipient of the Waterloo Institute of Nanotechnology Fellowship.

As a current active member of the Junior League of Austin, an organization focused on the strength of women and power of the community, Christine dedicates herself to the scientific and non-profit areas.

Christine holds both a bachelor’s and master’s degree in Biomedical Engineering from the University of Texas at Austin.